These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11181764)

  • 1. Is more better? Chemotherapy for patients with extensive-stage small-cell lung cancer.
    Johnson BE
    J Natl Cancer Inst; 2001 Feb; 93(4):254-5. PubMed ID: 11181764
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
    Hesketh PJ; McCoy J; Dunphy FR; Bearden JD; Weiss GR; Giguere JK; Atkins JN; Dakhil SR; Kelly K; Crowley JJ; Gandara DR
    J Thorac Oncol; 2006 Nov; 1(9):991-5. PubMed ID: 17409984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.
    Masuda N; Fukuoka M; Furuse K
    Oncology; 1992; 49 Suppl 1():19-24. PubMed ID: 1380148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
    Wolf M; Klausmann M; Havemann K
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase I/II trial of irinotecan plus amrubicin supported with G-CSF for extended small-cell lung cancer.
    Harada T; Hamada A; Shimokawa M; Takayama K; Kudoh S; Maeno K; Saeki S; Miyawaki H; Moriyama A; Nakagawa K; Nakanishi Y
    Jpn J Clin Oncol; 2014 Feb; 44(2):127-33. PubMed ID: 24379211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC).
    Girling DJ; Thatcher N; Clark PI; Stephens RJ
    Eur J Cancer; 1996 Jun; 32A(7):1263. PubMed ID: 8758266
    [No Abstract]   [Full Text] [Related]  

  • 7. Small-cell lung cancer, high growth rate, high response rate to chemotherapy: ideal for high-dose chemotherapy?
    Galani E; Ellis PA; Harper PG
    J Clin Oncol; 2002 Oct; 20(19):3941-3. PubMed ID: 12351589
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
    Thatcher N; Girling DJ; Hopwood P; Sambrook RJ; Qian W; Stephens RJ
    J Clin Oncol; 2000 Jan; 18(2):395-404. PubMed ID: 10637255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Bunn PA; Crowley J; Kelly K; Hazuka MB; Beasley K; Upchurch C; Livingston R; Weiss GR; Hicks WJ; Gandara DR
    J Clin Oncol; 1995 Jul; 13(7):1632-41. PubMed ID: 7602352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
    Pujol JL; Douillard JY; Rivière A; Quoix E; Lagrange JL; Berthaud P; Bardonnet-Comte M; Polin V; Gautier V; Milleron B; Chomy F; Chomy P; Spaeth D; Le Chevalier T
    J Clin Oncol; 1997 May; 15(5):2082-9. PubMed ID: 9164221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose intensity in small cell lung cancer.
    Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Cleopatra project].
    Lotz JP; Lecesne A; Trillet-Lenoir V
    Rev Pneumol Clin; 1999 Sep; 55(4):234-5. PubMed ID: 10573755
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
    Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone.
    Clemons M; Gharif R; Howell A
    Cancer Treat Rev; 1998 Jun; 24(3):173-84. PubMed ID: 9767733
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of leukomax for potentiating combined chemotherapy of small cell lung cancer].
    Gorbunova VA; Bychkov MB; Perevodchikova NI; Orel NF; Smirnova NB
    Vopr Onkol; 1995; 41(1):72-4. PubMed ID: 7667948
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose chemotherapy in small cell lung cancer.
    Pasini F; Pelosi G; De Manzoni G; Rosti G
    Tumori; 2002; 88(3):179-86. PubMed ID: 12195754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.
    Tjan-Heijnen VC; Postmus PE; Wagener DJ
    Anticancer Drugs; 1997 Jul; 8(6):549-64. PubMed ID: 9300569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
    Rosell R; Gómez-Codina J; Anton A; Sánchez JJ; Vadell C
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):48-53. PubMed ID: 8153657
    [No Abstract]   [Full Text] [Related]  

  • 20. Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
    Frasci G; Comella P; Carreca I; DeCataldis G; Muci D; Brunetti C; Russo A; Palmeri S; D'Aniello R; Giordano R; D'Aiuto M; Comella G;
    Oncology; 2005; 68(2-3):223-9. PubMed ID: 16015038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.